Zacks.com Featured Highlights Include: Halliburton Company, AmerisourceBergen, Cardinal Health, ABM Industries And Dillard's
Zacks Investment Research | Mar 24, 2020 09:29PM ET
For Immediate Release
Chicago, IL – March 25, 2020 – Stocks in this week’s article are Halliburton Company (NYSE:HAL) , AmerisourceBergen (NYSE:ABC) , Cardinal Health (NYSE:CAH) , ABM Industries (NYSE:ABM) and Dillard's (NYSE:DDS) .
5 Stocks Brokers Favor Amid Coronavirus Crisis
The coronavirus pandemic shook stock markets all around the globe, spooking investors in the process. Even though every nook and corner of the investing space is seen bearing the brunt of this health hazard, travel-focused stocks are one of the worst-hit with people unwilling to venture out, thereby shrinking travel demand and hurting revenues.
However, investors always look to make profits from their portfolios irrespective of the surrounding scenario. They are after all infusing their hard-earned money into the stock market. Therefore, in these trying times, it is best to design a well-diversified portfolio (including stocks from different spheres).
However, the task seems quite daunting as the market is chock-a-block with companies. Moreover, the complexities associated with the stock market make it even more difficult for individual investors to select outperformers for their portfolios in absence of proper guidance from “experts” in the field. These “experts” are brokers who are well-equipped with detailed knowledge on the space.
Brokers, irrespective of their types (sell-side, buy-side or independent), have at their disposal a deluge of information on a company’s profile and its prospects than individual investors. To enrich their database, they scan the minute details of the publicly available financial documents apart from attending company conference calls and other presentations.
Estimate revisions by brokers serve as a key pointer regarding the price of a stock. In fact, a rating upgrade generally leads to stock price appreciation. Similarly, the price of a stock may plummet following a rating downgrade.
Winning Strategy
The above write-up clearly suggests that by following broker actions, one can arrive at a gamut of lucrative stocks. Keeping this in mind, we designed a screen to shortlist stocks based on improving analyst recommendation and upward revisions of earnings estimates over the last four weeks.
Also, since the price/sales ratio is a strong complementary valuation metric in the presence of analyst information, it has been included. The price/sales ratio takes care of the company’s top line, making the strategy foolproof.
For the rest of this Screen of the Week article please visit Zacks.com at:Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.